5 Steps to Improve Communication in Laboratory Outreach - Insights
Communication is a critical component of success. Laboratory outreach leaders can foster truly effective communication with five simple steps.
Rapid response: COVID-19, monkeypox, and whatever comes next - Insights
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in...
Memorial Day Specimen Shipping Alert - Insights
Due to the Memorial Day holiday (recognized on Monday, May 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the...
Lab medicine is an ever-evolving field, and staying up to date can be a challenge. Mayo Clinic Laboratories' podcasts are designed to share the information you need to know about the latest developments in laboratory diagnostics.
Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide targeted cancer surveillance for...
Colorectal panel provides detailed cancer information - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.
Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. - Insights
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal...
NELL-1 [Test in Focus] - Insights
Sanjeev Sethi, M.D., Ph.D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic certainty and...
Novel malabsorption panel speeds diagnosis - Insights
Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ malabsorption panel can provide timelier diagnosis for children with chronic diarrhea or unexplained weight loss. The novel panel, which bundles four existing tests, requires just...
Due to a pending winter storm affecting the FedEx hub in Memphis, Tennessee, and the UPS hub in Louisville, Kentucky, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. Read...
Monitoring Hurricane Milton - Insights
Hurricane Milton is approaching the west coast of Florida and is anticipated to make landfall Wednesday. We continue to monitor and track the situation with our logistics partners to minimize challenges.
Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.
Mayo Clinic Laboratories and Lucence are expanding access to advanced cancer testing worldwide with LiquidHALLMARK®, a next-generation liquid biopsy that provides actionable genomic insights. This collaboration empowers physicians to...
Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D. - Insights
John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.
Neurofilament Light Chain (NFLC) - Insights
Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s...
Memorial Day 2024 Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming Memorial Day holiday on Monday, May 27, 2024. To ensure specimen stability and prevent delays, follow the guidelines below outlined for...
Labor Day Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming holiday. To ensure specimen stability and prevent delays, follow these guidelines.
Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. - Insights
Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating...
Precision therapeutics can individualize depression treatment - Insights
Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D., explain how precision therapeutics can improve treatment for patients with major depressive disorder. The optimal antidepressant medication and dose vary among individuals. Pharmacogenomic...
PCD test provides definitive diagnosis of a rare disease - Insights
Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D., explain how Mayo Clinic Laboratory can provide definitive diagnosis of primary ciliary dyskinesia (PCD). Mayo Clinic's expertise and technology have earned the laboratory's...
connective_tissue_disease_cascade.pdf
01/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Connective Tissue Disease Cascade ≥20 U <20 U CTDC / Connective Tissue Diseases Cascade, Serum Cyclic citrullinated peptide antibodies,...
hyperoxaluria_diagnostic_algorithm.pdf
10/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Adapted from “The Primary Hyperoxalurias: An Algorithm for Diagnosis,” American Journal of Nephrology 2005;25:154-160. By permission S. Karger AG,...
MGMR - Overview: Myasthenia Gravis Evaluation with Muscle-Specific Kinase (MuSK) Reflex, Serum
Diagnosing autoimmune myasthenia gravis (MG) in adults and children Distinguishing autoimmune from congenital MG in adults and children or other acquired forms of neuromuscular junction transmission disorders Establishing a quantitative...
MGLE - Overview: Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...
Mayo Clinic Labs @Work: Jason Majorowicz - Insights
As an event management coordinator for the Department of Laboratory Medicine and Pathology at Mayo Clinic, Jason Majorowicz acts as an investigator when something may deviate from its established process. With a background in biotechnology...
Mayo Clinic Labs @Work: Doug Smith - Insights
As a clinical specialty representative for Mayo Clinic Laboratories, Doug Smith works to promote Mayo Clinic’s core values and support community-based health care and integrated delivery systems through the sale of Mayo Clinic Laboratories...
What's New in Health Care Reform: Dec.12 - Insights
Top highlights include: how hospitals are fighting burnout, U.S. health spending hits $3.5 trillion but growth slows, why states might start taxing opioids, telemedicine in reverse. and health care providers are teaming with chatbots to...
Hereditary movement disorders - Insights
Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.
This featured section focuses on events, updates, and items of interest for Mayo Clinic Laboratories’ clients, health care providers, lab staff, and the public.
Mayo Clinic Laboratories’ pharmacogenomic testing offers superior analytical quality, enabling targeted detection of more clinically actionable alleles than other testing.
What's New in Health Care Reform Archives - Insights
Skip to Content MayoACCESS MayoLINK...
What's New in Health Care Reform: Dec. 19 - Insights
Top highlights include: NIH to spend up to $20 million on search for alternatives to fetal tissue for research, hospital beds get digital upgrade, cocaine deaths increase amid ongoing national opioid crisis, health insurers look to digital...
What's New in Health Care Reform: Dec. 5 - Insights
Top highlights include: Minnesota OKs medical marijuana to treat Alzheimer's, U.S. life expectancy declines again, polio-like disease in U.S. kids appears to have peaked for 2018, methamphetamine use by pregnant women, and the effects of...
Week in Review: July 16 - Insights
Top highlights include: a third dose of COVID-19 vaccine sparking debate over booster shots, rare reactions with the J&J COVID-19 vaccine, and can vaccinated people get long Covid.
Industry Archives - Page 4 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Industry Archives - Page 2 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Industry Archives - Page 3 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: November 8 - Insights
Top highlights include: Discovery of a new HIV strain, Google to acquire Fitbit, how to stay healthy while traveling during the holidays, and how a rare mutation protected a woman from developing Alzheimer's.
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...
Post-Bulletin Features Dr. Bobbi Pritt's "Creepy, Dreadful, Wonderful Parasites" Blog - Insights
The Rochester Post-Bulletin recently highlighted Bobbi Pritt, M.D.'s, “Creepy, Dreadful, Wonderful Parasites” blog, which celebrated its 10-year anniversary in October with a parasite-themed art contest and giveaways.
Bobbi Pritt, M.D., Advises How to Avoid Bug-Borne Diseases This Summer - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, recently spoke with the Post-Bulletin about Lyme disease and West...
Mayo Clinic Laboratory and Pathology Research Roundup: March 20 - Insights
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Mayo Clinic Laboratory and Pathology Research Roundup: May 1 - Insights
This week’s Research Roundup highlights the association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
Precision pain management - Insights
Our liquid chromatography-tandem mass spectrometry, high-resolution accurate mass (LC-MS/MS HRAM) screens, and confirmatory testing for controlled substances are available based on the needs of your patients.